4-(propan-2-ylamino)butan-1-ol

4-(Propan-2-ylamino)butan-1-ol (CAS 42042-71-7) is a pharmaceutical-grade intermediate offered by Hunan HuaTeng Pharmaceutical Co., Ltd., a global supplier of pharmaceutical intermediates, marketed specifically as an intermediate for Selexipag (Uptravi) suitable for R&D, evaluation, pilot and commercial-scale use with supportive technical documentation. The company sources rather than manufactures the compound and sells it across North America, Central/South America, Western Europe, Eastern Europe, Australasia and Asia.